... adult oncology patients 12 to 35 years old. We found uncommon, mild, and self-limiting side effects ...
... availability of multiple vaccines approved for use in adults and children 12 years old or older.1 Of importance ...
... reported in children 12 years and older.4 Adenopathy was reported as an unsolicited event in 1.1% of ...
... were included: (1) 12 years of age or older to 35 years or younger of age, (2) received any COVID-19 ...
... manuscript, only the Pzer vaccine was available for children older than 12 years of age. Patients who ...